Happiness Capital
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Epoch Biodesign
25 Mar 2026
Epoch Biodesign raises £9m in funding from lululemon and leading VCs for enzymatic nylon recycling
Epoch Biodesign develops enzymatic recycling technology that converts waste nylon materials back into their original chemical components. It enables manufacturers to produce new nylon without using virgin feedstock, helping apparel and automotive companies reduce reliance on raw materials.
Epoch Biodesign
5 Mar 2025
Epoch Biodesign raises £14m Series A led by Extantia Capital to scale plastic-eating enzyme technology
Epoch Biodesign uses engineered enzymes to break down plastic waste into reusable chemical building blocks, enabling higher-quality recycling at industrial scale.
Happiness Capital
- 1(12 months)
- happinesscapital.com
- Update Information
More venture news
- 29 Apr 2026
Third Space LearningThird Space Learning secures £4.4m in funding from Maven and Blackfinch Ventures to scale its AI tutoring platform
EquityEducation - 30 Apr 2026
Online OceansOnline Oceans lands £4m in funding led by Seraphim Space to build autonomous maritime surveillance fleets
EquityDefence - 27 Apr 2026
PlaqueTecPlaqueTec raises £3.7m investment from existing backers to develop site-of-disease cardiovascular insights
EquityHealth
